The present study investigates whether the replacement of dietary casein by soya protein isolate could be able to improve and/or even revert the morphological and metabolic abnormalities underlying the adipose tissue dysfunction of dyslipidaemic rats chronically fed (8 months) a sucrose-rich (62·5 %) diet (SRD). For this purpose, Wistar rats were fed a SRD for 4 months. From months 4 to 8, half the animals continued with the SRD and the other half were fed a SRD in which the source of protein, casein, was substituted by soya. The control group received a diet in which the source of carbohydrate was maize starch. Compared with the SRD-fed group, the results showed that: (1) soya protein decreased body-weight gain, limited the accretion of visceral adiposity and decreased adipose tissue cell volume without changes in total cell number; (2) soya protein increased the protein mass expression of PPARg, which was significantly reduced in the fat pad of the SRD-fed rats; (3) the activity of the enzymes involved in the de novo lipogenesis of adipose tissue was significantly decreased/normalised; (4) soya protein corrected the inhibitory effect of SRD upon the anti-lipolytic action of insulin, reduced basal lipolysis and normalised the protein mass expression of GLUT-4. Dyslipidaemia, glucose homeostasis and plasma leptin levels returned to control values. The present study provides data showing the beneficial effects of soya protein to improve and/or revert the adipose tissue dysfunction of a dyslipidaemic insulin-resistant rat model and suggests that soya could maintain the functionality of the adipose tissue -liver axis improving/reverting lipotoxicity.
The metabolic syndrome, a combination of medical disorders, increases the risk of CVD and type 2 diabetes. Insulin resistance and visceral adiposity are the core features of the syndrome (1) . The interaction of both genetic and environmental factors contributes to its development. The type of dietary protein appears to be a crucial factor involved in lipid, glucose and energy metabolisms in experimental animals and human subjects. In this regard, several studies have demonstrated the anti-lipogenic and anti-hypertensive effects of soya protein. In addition, other health benefits of dietary soya protein, which include antidiabetic effects improving glucose homeostasis and insulin sensitivity, have also been suggested (2) . In animal models of obesity (3) , soya protein ingestion limits or reduces weight gain and adiposity, and improves insulin resistance. Tovar et al. (4) have shown that dietary soya protein increases PPARg mRNA expression and reduces sterol regulatory element-binding protein-1 expression in adipocytes of Zucker diabetic fatty fa/fa rats preventing their hypertrophy. In both dietary and genetically obese rodents, Aoyama et al. (5) have demonstrated that diets containing soya protein isolate and its hydrolysate reduce body fat content when compared with a casein diet. Moreover, it has been reported that Wistar rats fed soya protein in a high-fat diet gain less weight than those fed casein, partially due to an increase in the thermogenesis capacity of mitochondrial uncoupling protein-1 (6) . In normal Wistar rats fed a soya protein isolate, Nagasawa et al. (7) have shown a decrease in the expression of adipose plasminogen activator inhibitor-1 and an increase in both the expression and plasma levels of adiponectin.
In rats in which stable dyslipidaemia, insulin resistance, moderate overweight and visceral adiposity developed by feeding them a sucrose-rich diet (SRD) for a long term (3 -8 months), we have recently shown that the addition of dietary soya protein instead of casein normalised dyslipidaemia, reverts hepatic steatosis and substantially improves whole-body insulin sensitivity. Moreover, soya protein moderately decreases body-weight gain, limiting the accretion of visceral fat (8) . In rats fed a SRD, in which casein was the source of protein, we have previously demonstrated that the hypertrophy of visceral adipose tissue was accompanied by both an alteration in adipocyte cell size distribution and an increase in the activities of several enzymes involved in de novo lipogenesis. In addition, adipocytes from the SRD-fed rats showed an increase in lipolysis and an impaired insulin-stimulated glucose uptake. Besides, a decrease in plasma levels and an increase in adipose tissue leptin storage without changes in their gene expression were observed (9 -11) . Interestingly, several of the metabolic abnormalities described in the SRD-fed rats are also present in the metabolic syndrome in human subjects.
The mechanisms whereby soya protein may exert its beneficial effects on visceral adiposity/overweight are not completely clear. Moreover, to the best of our knowledge, no study has been published focusing on the mechanisms by which soya protein improves overweight and visceral adiposity in SRD-fed rats. Given this information, we consider it worthwhile to assess whether or not the isoenergetic replacement of dietary casein by soya protein could be able to improve or even revert the morphological and metabolic abnormalities underlying the adipose tissue dysfunction in rats fed a long-term SRD. To test this hypothesis, the present study was designed to evaluate: (1) the number and volume of epididymal fat cells; (2) the activity of several enzymes involved in de novo lipogenesis; (3) in isolated adipocytes, basal lipolysis as an estimation of hormone-sensitive lipase and TAG lipase activities and the effect of insulin on lipolysis; (4) the protein mass expression of PPARg, since some of the metabolic alterations that follow the hypertrophied fat cell growth in visceral adiposity/obesity are associated with the expression of this nuclear receptor (12) ; (5) the protein mass expression of the glucose transporter GLUT-4.
Materials and methods

Animals and diets
Male Wistar rats initially weighing 170-185 g and purchased from the National Institute of Pharmacology (Buenos Aires, Argentina) were maintained in the animal room under controlled temperature (22^18C), humidity and air flow conditions, with a fixed 12 h light-dark cycle (light 07.00 -19.00 hours). They were initially fed a standard non-purified diet (Ralston Purina, St Louis, MO, USA). After 1 week of the acclimatisation period, they were randomly divided into two groups of rats (control and experimental) and were housed individually. The experimental group (n 48 rats) received a purified SRD containing by weight (g/100 g): 62·5 sucrose, 18 casein-free vitamins, 7 maize oil, 7·5 cellulose, 3·5 salt mixture (AIN-93M-MX), 1 vitamin mixture (AIN-93-VX), 0·2 choline chloride and 0·3 DL-methionine. The control group (n 24 rats) received the same purified diet but with sucrose replaced by maize starch (high-starch diet, control diet (CD)). Both groups received each diet for 4 months after which the SRD group of rats was randomly subdivided into two subgroups. The rats in the first subgroup continued on the SRD up to 8 months of feeding. The second subgroup, SRD with soya protein (SRD-S), received the SRD in which the source of protein (18 g casein/100 g) had been replaced by soya protein for the next 4 months. The control group was fed with the CD throughout the experimental period. In rats fed ad libitum a SRD for a long term (8 -9 months), we have previously reported that after 4 months on the diet, the animals began to increase both food intake and body weight compared with age-matched controls fed a CD (8, 9) . Both parameters were significantly different at 6 months and remained so at least until 8-9 months of feeding the diet (8, 9) . A different picture emerged when, after 4 months on a SRD, casein was replaced by soya (SRD-S) as a source of dietary protein. In this group, body weight and the amount of food intake remained similar to those observed in the CD-fed group (8) . Since in the above protocol the animals were fed ad libitum through the experimental period, there was a risk of uncontrollable bias associated with weight changes between the groups. Thus, in the present experimental design, both CD and SRD-S groups were offered the same amount of food, which was freely consumed daily by the SRD group throughout the feeding period. Details on the composition of the diets are given in Table 1 . The preparation of the diets has been reported elsewhere (8) . Diets were isoenergetic, providing approximately 16·3 kJ/g of food, and were prepared every week. The weight of each animal and the energy intake were recorded daily throughout the experimental time in all groups and subgroups of rats. At the end of the experimental period, food was removed at 07.00 hours (end of the dark period), and unless otherwise indicated, experiments were performed between 07.00 and 09.00 hours. At least six rats from the three dietary groups were used in each procedure. They were anaesthetised with intraperitoneal sodium pentobarbital (60 mg/kg body weight). Blood samples were obtained from the jugular vein and rapidly centrifuged. The plasma was either immediately assayed or stored at 2208C. Epididymal adipose tissue was totally removed, weighed and immediately used for the preparation of isolated adipocytes as mentioned below, or frozen and stored at the temperature of liquid N 2 . Retroperitoneal adipose tissue was removed and weighed. The experimental protocol was approved by the Human and Animal Research Committee of the School of Biochemistry, University of Litoral, Santa Fe, Argentina.
Analytical methods
Plasma TAG, NEFA and glucose levels were determined by spectrophotometric methods as previously described (13) .
Immunoreactive insulin was measured by the method proposed by Herbert et al. (14) . The immunoreactive insulin assays were calibrated against rat insulin standard (Novo Nordisk, Copenhagen, Denmark). Plasma leptin was determined by an ELISA kit (Linco Research, St Charles, MO, USA).
Preparation of isolated adipocytes and determination of fat cell volume and number
Epididymal fat pads were removed, weighed and rinsed in isotonic saline solution at 378C. Adipocytes were isolated according to the method of Rodbell with minor modifications as previously described (15) . One fraction of washed cells was used for the determination of fat cell size and number as previously described (10, 15) . The lipid weight of the average fat cell was calculated from mean cell volume assuming a lipid density of 0·95 (triolein density).
Determination of basal lipolysis
For the study of basal lipolysis, aliquots of diluted isolated epididymal fat cells (1 £ 10 5 cells/ml) were incubated in Krebs-Henseleit phosphate buffer (pH 7·0) containing 4 % of bovine serum albumin, essentially free of fatty acids, in a shaking Dubnoff water-bath (sixty cycles/min) at 378C for 1 h under an atmosphere of 95 % O 2 -5 % CO 2 , as previously described (15) . Under these conditions, there was a time-dependent increase in lipolysis for 60 min. Therefore, this time period was chosen for the incubation. Lipolysis was determined by measuring glycerol release over 1 h at 15 min intervals in aliquots of infranatant from each incubation mixture by the enzymatic method of Wieland (16) , as previously described (15) .
Assay of the anti-lipolytic action of insulin
The anti-lipolytic action of insulin was performed in epididymal isolated adipocytes according to Soria et al. (15) . Briefly, isoproterenol (10 -7 M) and adenosine deaminase
(1 U/ml) were added to the fat cell suspensions (1 £ 10 5 cells/ml), and incubations were conducted during 1 h at 378C under an atmosphere of 95 % O 2 -5 % CO 2 , both in the absence or presence of insulin (purified porcine insulin; Novo Laboratory, Burien, WA, USA) at a final concentration of 2·0 nM. At the end of the incubation, three aliquots of the infranatant were removed from each incubation mixture, and the glycerol release was measured as described above. The anti-lipolytic action of insulin was expressed as the ratio of the value of insulin-inhibited lipolysis to that of isoproterenol-stimulated lipolysis in the absence of the hormone as a percentage.
Determination of tissue leptin content
Leptin content was determined in fresh epididymal adipose tissue samples according to Peyron-Caso et al. (17) , as previously described (11) . Data are expressed as leptin concentration of epididymal adipose tissue as ng per total fat tissue weight.
Enzymatic activity assays
For the assay of acetyl-CoA carboxylase activity, the frozen fat pad (1 g) was homogenised with 3 vol. of phosphatebicarbonate buffer (70 mM-KHCO 3 , 85mM-K 2 HPO 4 , 9mM-KH 2 PO 4 and 1 mM-dithiothreitol (pH 7·0)). After centrifugation at 20 000 g, the fat cake was discarded, and the cytosolic fraction was obtained after centrifugation of the supernatant at 100 000 g for 1 h at 48C. Acetyl-CoA carboxylase was measured by an NADH-linked assay (18) . The assay medium (56 mM-Tris-HCl (pH 8·0), 10 mM-MgCl 2 , 11 mM-EDTA, 4 mM-ATP, 52 mM-KHCO 3 , bovine serum albumin (0·75 mg/ml), 0·5 mM-NADH and 1·4 mM-phosphoenolpyruvate) was mixed with pyruvate kinase and lactate dehydrogenase (each 5·6 U/ml). The baseline was followed at 308C until a constant slope was reached. For each 2·3 vol. of medium, 1 vol. of the activated homogenate was added, and the reaction was started with acetyl-CoA (final concentration 0·125 mM). For enzyme activation, 1 vol. of the homogenate was incubated with 1 vol. of activation buffer (20 mM-citrate, 100 mM-Tris-HCl (pH 8·0), bovine serum albumin (1·5 mg/ml), 20 mM-MgCl 2 and 20 mM-GSH (pH 7·5)) for 15 min at 378C. Fatty acid synthase activity was assayed on the cytosolic fraction of adipose tissue by measuring the malonyl-CoA-dependent oxidation of NADPH at 378C, as previously described (9) . Malic enzyme activity was measured in the aqueous supernatant fraction of adipose tissue samples by the spectrophotometric method of Wise & Ball (19) . Adipose tissue glucose-6-phosphate dehydrogenase activity was measured according to Cohen et al. (20) , as described elsewhere (21) . Lipoprotein lipase (LPL) activity was analysed by the method of Martin Hidalgo et al. (22) . Briefly, tissue samples were homogenised in 0·2 mM-hydroxymethyl aminomethane (Tris)-HCl, pH 8·2, at 48C and delipidated with acetone-diethyl ether. LPL activity was assayed in triplicate in an assay medium containing triolein (5·7 mM), egg lecithin (0·3 mg/ml), bovine serum albumin (2 g%), Tris (pH 8·5) and 8 % heated rat serum in the absence or presence of 1 mM-NaCl (high salt). LPL activity was determined by subtracting non-LPL-dependent activity (high salt) from the total lipolytic activity. Enzyme activity was expressed as pmol of substrate transformed per second (pktal) per g of fresh tissue.
Carcass composition
Six rats from each dietary group were anaesthetised as mentioned above. The anaesthetised rats were shaved, and the visceral organs were removed. Carcasses were weighed, placed in plastic bags and frozen at 2 208C. Each frozen carcass was ground to a homogeneous mixture with a mill cooled with liquid N 2 , and the ground carcass was stored individually at 2 208C. Carcass water, ether-extractable fat and nitrogen determination as an estimation of protein content and ash content were performed in duplicate samples, as previously described (10) .
Western blot analysis of adipose tissue PPARg
Frozen epididymal adipose tissue powder was homogenised as previously described (23) . Total protein samples (40 mg) were resolved on 10 % SDS-PAGE. Polyvinylidene fluoride-blocked membranes were incubated overnight with 1:400 specific polyclonal goat anti-PPARg antibody (PPARg; H-98; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) at 48C, followed by anti-goat horseradish peroxidase-conjugated antibody (1:2000) at room temperature. PPARg was visualised by chemiluminescent detection according to the manufacturer's instructions (Super Signal West Pico chemiluminescence substrate; Pierce Biotechnology, Rockford, IL, USA). The PPARg expression was normalised to b-actin. The intensity of the bands was quantified by NIH imaging software. The correlation coefficient between the amount of protein (25 -100 mg) and the enhanced chemiluminescence image intensity was 0·985. The relationship between the amount of sample subjected to immunoblotting and the signal intensity observed was linear under the conditions described above. The skeletal muscle tissue extract was employed as a PPARg-positive control. Protein concentrations were quantified with the Bio-Rad Protein assay.
Western blot analysis of adipose tissue glucose transport (GLUT-4) at the start and at the end of the euglycaemichyperinsulinaemic clamp study
The euglycaemic -hyperinsulinaemic clamp technique as described earlier (8, 24) was used to analyse the adipose tissue GLUT-4 protein mass expression at the start (0 min) and at the end (120 min) of the clamp study. Immediately after the clamp, the rats were killed, and their epididymal adipose tissue was rapidly excised, cleaned of extraneous tissues and frozen in liquid N 2 . The adipose tissue was kept at 2 808C until further processing. GLUT-4 was measured according to Kamel et al. (25) . Briefly, approximately 1 g of adipose tissue was homogenised for 5 s in an ice-cold buffer (25 mM-HEPES, 250 mM-sucrose, 4 mM-EDTA, 0·2 mM-phenylmethylsulphonyl fluoride, 1 mMleupeptin, aprotinin (1 U/ml) and 0·1 mM-sodium vanadate (pH 7·4)). Homogenates were centrifuged at 5000 g for 5 min at 48C. To obtain the membrane fraction, the supernatant was centrifuged at 200 000 g for 90 min at 48C. The pellet was dissolved in an ice-cold homogenisation buffer. Total protein samples (20 mg) were resolved on 10 % SDS-PAGE (Laemmli). Blocked membranes were incubated overnight with a 1:600 specific polyclonal goat anti-GLUT-4 antibody (GLUT-4, C-20; Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA) at 48C, followed by an anti-goat horseradish peroxidase-conjugated antibody (1:2000) at room temperature. GLUT-4 was visualised by chemiluminescence detection as mentioned above. GLUT-4 expression was normalised to b-actin. The intensity of the bands was quantified by NIH imaging software. Preliminary studies showed linearity of Western blot assay from 15 to 100 mg of protein. The correlation coefficient between the amount of protein and the enhanced chemiluminescence image intensity was 0·97 for the GLUT-4 fraction. The relationship between the amount of the sample subjected to immunoblotting and the signal intensity observed was linear under the conditions described above. Protein concentrations were quantified with the Bio-Rad Protein assay.
Statistical analysis
Sample sizes were calculated on the basis of measurements previously made with rats fed either a CD or a SRD (10, 15, 21) , considering an 80 % power. Data are expressed as means with their standard errors. Statistical comparisons were done transversely between different dietary groups. The statistical significance between groups was determined by one-way ANOVA, with one factor (diet) followed by the inspection of all differences between pairs of means by the Newman -Keuls test. Differences having P values lower than 0·05 were considered to be statistically significant (26) . In all cases, the interclass correlation coefficients were at least 0·73.
Results
Body-weight gain, energy intake, carcass weight and composition, adipose tissue cellularity and plasma metabolites and insulin levels A comparable body-weight gain and energy intake were recorded in rats fed the CD or SRD during the first 4-month feeding period on their respective diets. The values were as follows: initial body weight was 184·0 (SEM 5·4) g in rats fed a CD (n 24); 188·8 (SEM 4·5) g in the SRD group (n 48). Body weight at 4 months was 422·0 (SEM 0·8) g in rats fed a CD and 417·8 (SEM 6·7) g in the SRD group. Energy intake initially to month 4 was 257·4 (SEM 5·9) kJ/d in rats fed a CD and 255·0 (SEM 6·3) kJ/d in the SRD group. From 4 to 8 months of the experimental period, rats fed a SRD showed a significant increase in body-weight gain and energy intake compared with both rats fed the CD and SRD in which soya protein replaced casein (SRD-S). Moreover, body-weight gain and energy intake were similar in both SRD-S-and CD-fed rats (Table 2) . These data confirm a recent publication of our group (8) . Rats fed a SRD during 8 months showed a significant increase in carcass weight and fat content with a decrease in water content when compared with the CD-fed group.
Moreover, a significant reduction of both carcass weight and fat content and an increase in water content occurred when casein was replaced by soya protein from month 4 to 8 in the SRD group. However, values reached by the SRD-S group were still above those recorded in the agematched control rats fed a CD (Table 2) . Soya protein reduced the volume (hypertrophy) observed in adipocytes from the epididymal fat pad of the SRD-fed rats, although the values were still higher than those recorded in the CDfed group. The values were as follows (six animals per group): cell volume was 275·2 (SEM 16·6) pl in rats fed a CD; 851·5 (SEM 13·3) pl in the SRD group and 552·8 (SEM 11·2) pl in those fed the SRD-S (P, 0·001 SRD v. CD and SRD-S; P, 0·001 SRD-S v. CD). However, as shown in Table 2 , there were no differences in total cell number when expressed as total fat pads in all dietary groups.
Plasma TAG, NEFA and glucose levels were higher in rats fed a SRD both at 4 months (data not shown) and at 8 months compared with age-matched control rats fed a starch diet. Moreover, when soya protein replaced casein from the last 4 months of the diet, a significant reversal of all parameters was observed, matching values to those of the control rats. At the end of the experimental period, no statistically significant differences in plasma insulin levels were recorded among all dietary groups (Table 2) .
Fat pad weight and leptin content and plasma leptin levels Table 3 shows a significant decrease in both the accretion of epididymal fat weight and leptin content when soya protein replaced casein as a dietary protein in the Table 2 . Body-weight gain, energy intake, carcass weight and composition, adipose tissue cellularity and plasma metabolites and insulin levels of rats fed on a control diet (CD), a sucrose-rich diet (SRD) or the SRD with soya protein (SRD-S) ‡ SRD-fed rats. However, these values were still significantly above those recorded in the CD-fed group. Besides, plasma leptin returned to the values recorded in agematched controls fed a CD.
Glucose-6-phosphate dehydrogenase, fatty acid synthase, acetyl-CoA carboxylase, malic enzyme and lipoprotein lipase activities
As shown in Table 4 , the activities of enzymes related to de novo lipogenesis were significantly increased in the epididymal fat pad of rats chronically fed a SRD compared with those fed a CD. A significant reduction of both glucose-6-phosphate dehydrogenase and fatty acid synthase activities was observed in the SRD-S group, which reached values similar to those recorded in the CD-fed rats. Moreover, the addition of soya protein significantly decreased malic enzyme and LPL activities, even though their values were still higher than those observed in the CD-fed rats. Besides, although no changes in acetyl-CoA carboxylase activity were observed when the enzyme was expressed as mU/mg of protein, a behaviour similar to that of the other enzymes was observed when the enzymatic activity was expressed as U/g of total fat (data not shown).
Basal lipolysis and insulin-mediated inhibition of lipolysis of the fat cells Table 5 shows the effect of dietary soya protein on basal lipolysis (as an estimation of both hormone-sensitive lipase and TAG lipase enzyme activities). It can be seen that the increased basal lipolysis observed in the enlarged epididymal fat cells of the SRD-fed rats was significantly decreased when dietary soya protein replaced casein in this group of animals during the last 4 months of treatment. In addition, the higher levels of plasma NEFA present in the rats on a SRD were completely normalised after soya protein administration. Animals fed on a SRD showed a decrease in adipocyte sensitivity to the anti-lipolytic action of insulin. The hormone was unable to inhibit b-agonist-stimulated lipolysis in the isolated epididymal fat cell as compared with the CD-fed rats. Moreover, the replacement of casein by dietary soya to the SRD completely restored the sensitivity of adipocyte to the anti-lipolytic action of insulin.
Protein mass expression of PPARg
The immunoblotting of adipose tissue revealed a single 67 kDa band consistent with PPARg. Each gel contained an equal number of samples from the CD, SRD and SRD-S group ( Fig. 1(a) ). After the densitometry of immunoblots, the PPARg of the CD group was normalised to 100 %, and both SRD and SRD-S were expressed relative to this. Qualitative and quantitative analyses of Western blot showed that the relative abundance of PPARg was significantly decreased in the epididymal fat pad of the SRD group when compared with rats fed a CD ( Fig. 1(b) ). Even Mean values were significantly different from those of the CD and SRD-S: ** P, 0·01, *** P, 0·001. Mean values were significantly different from those of the CD: † † P,0·01.
‡ For details of procedures and diets, see Materials and methods section and Table 1 . Mean values were significantly different from those of the CD: * P, 0·05, ** P, 0·01, *** P, 0·001. Mean values were significantly different from those of the SRD: † P, 0·05, † † P, 0·01. Mean values were significantly different from those of the SRD-S: ‡ P, 0·05. § For details of procedures and diets, see Materials and methods section and Table 1 .
though the replacement of casein with soya protein in the SRD during the last 4 months of the experimental period improved PPARg protein mass expression, the values were still lower than those observed in the CD group.
GLUT-4 protein mass expression of adipose tissue
The immunoblotting of adipose tissue revealed a single 45 kDa band consistent with GLUT-4. Each gel contained an equal number of samples from rats fed a CD, SRD and SRD-S at the start (0 min) and at the end (120 min) of the euglycaemic -hyperinsulinaemic clamp ( Fig. 2(a) ). After the densitometry of immunoblots, the GLUT-4 of the CD group at the start of the clamp was normalised to 100 %, and both SRD and SRD-S at the start as well as the three dietary groups at the end of the study were expressed relative to this. At the start of the clamp, the qualitative and quantitative analyses of Western blot showed no differences in the relative abundance of GLUT-4 between the three dietary groups. Under insulin stimulation (at the end of the clamp), the translocation to the plasma membrane of GLUT-4 protein mass expression significantly increased in rats fed either a CD or SRD-S, while no changes were observed in the SRD-fed group (Fig. 2(b) ). Mean values were significantly different from those of the CD and the SRD-S: ** P, 0·01. Mean values were significantly different from those of the CD: † P, 0·05.
‡ For details of procedures and diets, see Materials and methods section and Table 1 . § The results are expressed as the ratio of the value of the insulin-inhibited lipolysis to that of the isoproterenol-stimulated lipolysis in the absence of insulin. 
Discussion
Expanding our previous research (8) , the present study provides new information concerning the cellular mechanisms behind the beneficial effects of dietary soya protein to improve and/or reverse the morphological and physiological abnormalities underlying the adipose tissue dysfunction, which develops in rats rendered dyslipidaemic and insulin resistant by chronically feeding a SRD.
The major new findings of the present study are the following: (1) soya protein markedly reduced body-weight gain, limited the accretion of visceral adiposity and improved adipose tissue cell volume without changes in total cell number. This was accompanied by a significant decrease in body fat content while maintaining body protein. (2) The relative abundance of PPARg was significantly decreased in the hypertrophied visceral fat pad of the SRD-fed rats. Even though the presence of dietary soya protein in the SRD improved the protein mass expression of this nuclear receptor, the values reached were still lower than those recorded in the CD-fed rats. (3) Soya protein normalised and/or improved the activities of the enzymes involved in de novo lipogenesis in the adipose tissue of the SRD-fed rats. (4) The presence of dietary soya corrected the inhibitory effect of the high-sucrose diet upon the antilipolytic action of insulin, and significantly reduced the enhanced basal lipolysis. (5) The significant decrease in the protein mass expression of GLUT-4 recorded in the fat pad of the SRD-fed rats under the stimulus of insulin reached values similar to those of the CD group by shifting the source of dietary protein in the SRD from casein to soya during the last 4 months of the feeding period. Finally, dyslipidaemia, glucose homeostasis and plasma leptin returned to levels similar to those of the control group after soya protein administration.
A number of studies have suggested that the consumption of soya protein has favourable effects on obesity. Among them, it increases the thermogenesis capacity of uncoupling protein-1 that increases energy expenditure; it also increases triiodothyronine production, reduces food intake and increases satiety, which may reduce body fat and weight gain (3, 6, 27, 28) . Confirming previous results (8) , the present data show that when soya replaces casein in the SRD during the last 4 months of the feeding period, the amount of food intake as well as bodyweight gain are significantly lower than those recorded in the age-matched rats fed a SRD -casein. These effects are accompanied by a decrease in visceral adiposity and carcass fat contents.
Soya protein contains many bioactive compounds or nutrients that may have multiple mechanisms of action; therefore, in nutritional intervention trials, it is difficult to disentangle the effect of any one constituent on bodyweight and food intake reduction. In this regard, some studies have reported that soya protein rich in isoflavones reduces fat pad mass (29) , while others showed no substantial differences in body weight and visceral fat by feeding rats soya protein diets in the presence or absence of added isoflavones (30) . Besides, in animal models of obesity, soya protein decreases body weight and visceral fat (3) . On the other hand, the gut endocrine system plays a major role in regulating ingestive behaviour, and a number of gutderived hormonal signals have been characterised. Among them, cholecystokinin released from the duodenum is a physiological mediator that acts as a short-term satiety signal (31) . The present results do not provide data concerning the mechanism(s) underlying the effect of dietary soya protein that leads to a reduction of food intake in the SRD-fed rats. However, some clues have been provided by recent publications. For instance, it has been shown that soyabean b-conglycinin -the main soybean proteinreduces food intake and gastric emptying by increasing cholecystokinin levels in rats (32) . Nishi et al. (33) showed that specific fragments of soya peptides rich in arginine residues have a strong food intake suppressor activity. Besides, soya protein digestion releases biologically active peptides that stimulate peripheral opioid and cholecystokinin-A receptors in rats (34) . It is possible that the mechanism(s) mentioned above are involved in the reduction of food intake contributing to the decrease in visceral adiposity and weight gain when soya protein replaces casein in rats chronically fed a SRD.
Recently, Rossi et al. (9) demonstrated that the long-term consumption of a high-sucrose diet induces adipocyte hypertrophy and dysfunction. Some of the metabolic alterations that follow the hypertrophic fat cell growth are associated with the expression of PPARg. In this regard, Brun & Spiegelman (35) showed that in adipocytes of both obese mice and human subjects, PPARg mRNA contents were significantly decreased. Accordingly, the present study shows a significant reduction of PPARg protein mass expression in the enlarged adipocytes from the epididymal fat pad of the SRD-fed rats. This may contribute to the impaired capacity of adipocytes to esterify fatty acids into TAG and therefore increase fatty acid release to the blood stream as shown by the increase in both plasma NEFA levels and in vitro basal lipolysis.
On the other hand, our data show that in the SRD-S-fed rats, the protein mass expression of PPARg, even though improved, was still lower compared with that of rats fed a CD. The effect of dietary soya protein upon the PPARg expression in adipose tissue is controversial. Mezei et al.
(36) demonstrated that soya protein-associated isoflavone genistein was able to activate PPARg in murine macrophage-like RAW 264.7 cells, resulting in an up-regulation of adipogenesis and probably fatty acid uptake from the plasma. Moreover, in Zucker diabetic fatty fa/fa rats fed a soya protein, adipose tissue PPARg mRNA levels were significantly increased compared with those of rats fed casein (4) . In contrast, Takahashi et al. (30) , in the epididymal fat pad of rats fed with soya protein isolate either alone or in the presence of isoflavone, showed that PPARg2 mRNA levels were not different from those recorded in rats fed casein, and Nagasawa et al. (7) did not observe any changes in PPARg mRNA levels in the fat pad of Wistar rats fed a soya protein isolate as compared with those fed casein.
Dietary soya protein in the SRD-fed rats significantly reduces adipose tissue de novo lipogenic rate (decreases fatty acid synthase, malic enzyme, glucose-6-phosphate dehydrogenase and acetyl-CoA carboxylase activities) as well as the LPL activity, which contributes to the reduction of adipocyte cell volume and consequently epididymal fat pad hypertrophy. Tovar et al. (4) recently demonstrated that the sterol regulatory element-binding protein-1 expression was lower in the epididymal adipose tissue of Zucker diabetic fatty fa/fa rats fed soya protein compared with that of Zucker diabetic fatty fa/fa rats fed casein, thus indicating a reduction of de novo lipogenesis reflected in a decrease in fat pad hypertrophy.
Additionally, rats fed a SRD showed an increase in both visceral adiposity and leptin store in the epididymal fat pad, together with a decrease in plasma leptin levels when compared with the CD-fed rats. These results are in agreement with a recent publication by Selenscig et al. (11) , which suggests that enhanced lipolysis and altered insulin sensitivity could be involved in the decrease in leptin release in this dietary group. The present data show that by shifting the source of protein from casein to soya in the SRD group, plasma leptin returned to the values recorded in the CD group. Moreover, a significant decrease in leptin content within the adipose tissue correlated with the decrease in fat pad accretion.
The release of fatty acid from adipocytes depends on the rate of lipolysis mediated by hormone-sensitive lipase and TAG lipase activities. The activities of those enzymes on the lipid stored in adipocytes are restricted by the abundance of perilipins surrounding the lipid droplet membrane. We have previously reported an increase in basal lipolysis in the engorged dysfunctional adipocyte from SRD-fed rats (9) . The present results show that the substitution of casein by soya protein decreases intracellular lipolysis. This is associated with a small adipocyte cell size, reduction of the fatty acids influx through the circulation and, therefore, normalising plasma NEFA levels. Torre-Villalvazo et al. (6) in rats fed either casein or soya protein in a low-or high-fat diet showed that in the adipose tissue of rats fed soya, perilipin expression was higher than in those fed casein, limiting the release of fatty acids. Besides, the administration of soya was able to reverse the impaired anti-lipolytic action of insulin present in the fat pad of rats fed a SRD. Together, these findings suggest that soya protein intake may limit adiposity at least in part by decreasing food intake as well as reducing the number of dysfunctional adipocytes, as a result of low lipogenesis and lipolysis. In addition, we have recently demonstrated (8) that soya protein reverts hepatic steatosis, and normalises VLDL-TAG secretion and dyslipidaemia in rats chronically fed a SRD. Since it is known that soya markedly decreases hepatic mRNA and the activities of lipogenic enzymes, it is likely that maintaining the number of functional adipocytes could also prevent the excessive transfer of fatty acids to other tissues (e.g. liver and muscle) decreasing its lipotoxicity.
The ultimate step involved in the activation of glucose transport by insulin in adipose cells is the translocation of GLUT-4 to the cell surface, namely the plasma membrane. We have recently demonstrated (9) an impairment of insulin-stimulated glucose uptake in isolated adipocytes from rats chronically fed a SRD. Accordingly, the present results show a complete abrogation of insulin-stimulated GLUT-4 translocation into the plasma membrane in the dysfunctional adipocytes of the SRD-fed rats. The present data are in line with previous results that showed a reduced adipose tissue insulin action and increased whole-body insulin resistance in this dietary group (9, 10) . Shifting the source of dietary protein from casein to soya in the SRD group significantly increased the translocation of GLUT-4 protein mass expression under the stimulus of insulin, reaching values similar to those recorded in the CD group. Adipose tissue accounts for only a small fraction of total glucose disposal in the intact organism. However, we have recently demonstrated that under the same experimental conditions, soya protein reversed the impaired glucose homeostasis without changes in plasma insulin levels and significantly improved whole-body insulin resistance (8) . Iritani et al.
(37) showed an increased insulin receptor mRNA in the adipose tissue and liver and decreased insulin resistance in Wistar fatty rats fed a soya protein isolate v. casein. Recently, Cho et al. (38) showed in murine 3T3-L1 preadipocytes and C3H10T1/2 cells that both daidzein and its metabolite equol enhance insulin-stimulated glucose uptake by increasing the expression of GLUT-4 and insulin receptor substrate 1 possibly via the activation of PPARg. Besides, Davis et al.
(39) demonstrated that dietary isoflavones increased GLUT-4 and PPARg protein in the adipose tissue of diabetic Zucker fatty rats.
In brief, the present study provides new information about several mechanism(s) that could be involved in the beneficial effects of dietary soya protein to revert and/or improve the adipose tissue dysfunction of the dyslipidaemic insulin-resistant rat model. These results suggest that soya protein could maintain the functionality of the adipose tissue-liver axis by improving and/or reversing lipotoxicity. Moreover, the reduction of food intake by dietary soya could contribute by itself to some of the above-discussed effects. Finally, although care must be taken in extrapolating results from rats to humans, the dyslipidaemic rats fed dietary soya as a source of protein constitute a useful animal model to study the diet regulation of these metabolic abnormalities. 
